In this episode I speak to Tim Harrington, Founder and CEO at Battlefin, the alternative data discovery and events business that recently announced its acquisition of Exabel, the alternative data technology platform.

In our conversation, Tim and I discuss the new acquisition, Battlefin’s history, the future of alternative data events and what data seems to be most in demand right now.

Wishing all listeners a very Happy Christmas and New Year.

DISCLAIMER

This podcast is an edited recording of an interview with Tim Harrington recorded in December 2024. The views and opinions expressed in this interview are those of Tim Harrington and Mark Fleming-Williams and do not necessarily reflect the official policy or position of either CFM or any of its affiliates. The information provided herein is general information only and does not constitute investment or other advice. Any statements regarding market events, future events or other similar statements constitute only subjective views, are based upon expectations or beliefs, involve inherent risks and uncertainties and should therefore not be relied on. Future evidence and actual results could differ materially from those set forth, contemplated by or underlying these statements. In light of these risks and uncertainties, there can be no assurance that these statements are or will prove to be accurate or complete in any way.

Hosted on Acast. See acast.com/privacy for more information.

This is the first ever live recorded episode, which took place at Neudata’s Winter Summit in New York on December 5th.

For the panel, I was fortunate to share the stage with Matei Zatreanu of System 2, Tjeerd van Cappelle of aiLiftoff, Alexander Izydorczyk of CyberSyn and Kelly Kosciuszka of Schulte, Roth & Zabel, as we embarked on an attempt to predict the Future of Alternative Data in five years time.

In our conversation we covered topics like innovation in datasets, the impact of LLMs, the new US administration’s regulatory plans, consolidation in the space, the structure of hedge funds, and more.

DISCLAIMER

This podcast is an edited recording of an interview with recorded in at the Neudata Winter Summit Event in December 2024. The views and opinions expressed in this interview are those of the event panelists and Mark Fleming-Williams and do not necessarily reflect the official policy or position of either CFM or any of its affiliates. The information provided herein is general information only and does not constitute investment or other advice. Any statements regarding market events, future events or other similar statements constitute only subjective views, are based upon expectations or beliefs, involve inherent risks and uncertainties and should therefore not be relied on. Future evidence and actual results could differ materially from those set forth, contemplated by or underlying these statements. In light of these risks and uncertainties, there can be no assurance that these statements are or will prove to be accurate or complete in any way.

Hosted on Acast. See acast.com/privacy for more information.

In this episode I speak to Wenqi Zhou, a quantitative researcher currently on gardening leave after stints at Balyasny and Citi.

In our conversation, Wenqi and I discuss the different uses of data on the sellside and the buyside, and her view on the current state of the China market.

I will be moderating the New Provider Showcase at Battlefin London on November 21st, do come and say hi if you’re there.

DISCLAIMER

This podcast is an edited recording of an interview with Wenqi Zhou recorded in November 2024. The views and opinions expressed in this interview are those of Wenqi Zhou and Mark Fleming-Williams and do not necessarily reflect the official policy or position of either CFM or any of its affiliates. The information provided herein is general information only and does not constitute investment or other advice. Any statements regarding market events, future events or other similar statements constitute only subjective views, are based upon expectations or beliefs, involve inherent risks and uncertainties and should therefore not be relied on. Future evidence and actual results could differ materially from those set forth, contemplated by or underlying these statements. In light of these risks and uncertainties, there can be no assurance that these statements are or will prove to be accurate or complete in any way.

Hosted on Acast. See acast.com/privacy for more information.